Hindustan Foods Ltd
Hindustan Foods Limited is an India-based company, which is engaged in contract manufacturing of various FMCG products including food, home care, personal care, beverages etc. They also do manufacturing of leather shoes and accessories
- Market Cap ₹ 6,220 Cr.
- Current Price ₹ 513
- High / Low ₹ 585 / 442
- Stock P/E 50.7
- Book Value ₹ 91.0
- Dividend Yield 0.00 %
- ROCE 14.1 %
- ROE 12.6 %
- Face Value ₹ 2.00
Pros
- Company has delivered good profit growth of 25.5% CAGR over last 5 years
- Company's median sales growth is 50.3% of last 10 years
Cons
- Stock is trading at 5.64 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 13.8% over last 3 years.
- Promoter holding has decreased over last 3 years: -3.54%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17 | 24 | 38 | 139 | 492 | 772 | 1,407 | 2,021 | 2,383 | 2,381 | 2,734 | 3,276 | |
| 23 | 22 | 35 | 128 | 459 | 716 | 1,317 | 1,905 | 2,236 | 2,219 | 2,521 | 3,032 | |
| Operating Profit | -6 | 2 | 3 | 10 | 33 | 56 | 90 | 115 | 147 | 163 | 213 | 244 |
| OPM % | -33% | 9% | 8% | 7% | 7% | 7% | 6% | 6% | 6% | 7% | 8% | 7% |
| 11 | 0 | 0 | 1 | 1 | 1 | 3 | 5 | 5 | 10 | 19 | 18 | |
| Interest | 2 | 1 | 1 | 1 | 8 | 11 | 19 | 20 | 27 | 38 | 47 | 49 |
| Depreciation | 1 | 1 | 1 | 1 | 7 | 11 | 19 | 24 | 29 | 39 | 45 | 52 |
| Profit before tax | 2 | -0 | 1 | 9 | 18 | 35 | 54 | 77 | 96 | 96 | 139 | 161 |
| Tax % | 0% | -2,980% | 19% | 27% | 35% | 34% | 28% | 35% | 33% | 19% | 26% | 26% |
| 2 | 1 | 1 | 6 | 12 | 23 | 39 | 50 | 65 | 78 | 103 | 119 | |
| EPS in Rs | 1.00 | 0.58 | 0.10 | 0.97 | 1.76 | 2.14 | 3.71 | 4.44 | 5.72 | 6.83 | 8.79 | 9.99 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 64% |
| 5 Years: | 18% |
| 3 Years: | 11% |
| TTM: | 20% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 56% |
| 5 Years: | 26% |
| 3 Years: | 24% |
| TTM: | 19% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 35% |
| 5 Years: | 1% |
| 3 Years: | -3% |
| 1 Year: | -7% |
| Return on Equity | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 15% |
| 3 Years: | 14% |
| Last Year: | 13% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 13 | 13 | 13 | 21 | 21 | 23 | 23 | 23 | 24 | 24 |
| Reserves | -7 | -5 | 19 | 24 | 51 | 166 | 235 | 285 | 349 | 605 | 828 | 1,064 |
| 11 | 13 | 5 | 34 | 100 | 165 | 219 | 274 | 347 | 507 | 522 | 571 | |
| 8 | 7 | 13 | 46 | 102 | 188 | 265 | 305 | 358 | 402 | 484 | 679 | |
| Total Liabilities | 17 | 19 | 50 | 118 | 266 | 540 | 741 | 886 | 1,076 | 1,537 | 1,858 | 2,338 |
| 9 | 9 | 9 | 39 | 133 | 250 | 308 | 396 | 402 | 593 | 545 | 775 | |
| CWIP | 2 | 2 | 3 | 3 | 0 | 26 | 53 | 9 | 45 | 5 | 99 | 19 |
| Investments | 0 | 0 | 0 | 0 | 0 | 3 | 3 | 7 | 80 | 84 | 127 | 138 |
| 6 | 8 | 38 | 75 | 133 | 261 | 377 | 474 | 549 | 855 | 1,086 | 1,407 | |
| Total Assets | 17 | 19 | 50 | 118 | 266 | 540 | 741 | 886 | 1,076 | 1,537 | 1,858 | 2,338 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 1 | -5 | -5 | -5 | 17 | 73 | 54 | 102 | 48 | 82 | 65 | |
| -1 | -1 | -14 | -19 | -40 | -145 | -91 | -103 | -167 | -347 | -118 | -191 | |
| 0 | 0 | 24 | 26 | 43 | 153 | 34 | 32 | 47 | 294 | 75 | 93 | |
| Net Cash Flow | 0 | 0 | 5 | 2 | -2 | 24 | 16 | -17 | -18 | -6 | 39 | -33 |
| Free Cash Flow | -0 | -0 | -9 | -8 | -46 | -111 | 1 | 1 | 28 | -22 | -35 | -65 |
| CFO/OP | -18% | 93% | -178% | -42% | -2% | 44% | 100% | 72% | 81% | 37% | 47% | 44% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 47 | 56 | 66 | 76 | 32 | 18 | 13 | 13 | 13 | 15 | 18 | 21 |
| Inventory Days | 108 | 37 | 90 | 139 | 54 | 74 | 58 | 52 | 61 | 87 | 107 | 93 |
| Days Payable | 184 | 103 | 166 | 237 | 85 | 94 | 74 | 60 | 58 | 67 | 74 | 67 |
| Cash Conversion Cycle | -29 | -10 | -10 | -21 | 1 | -2 | -3 | 5 | 16 | 35 | 50 | 47 |
| Working Capital Days | -19 | 3 | 36 | 42 | -8 | 7 | 8 | 12 | 14 | 31 | 51 | 59 |
| ROCE % | 34% | 8% | 7% | 19% | 22% | 18% | 18% | 18% | 19% | 14% | 15% | 14% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Number of Manufacturing Units Number |
|
||||||||
| Installed Capacity - Detergent Powder TPA |
|||||||||
| Installed Capacity - Extruded Food & Snacking TPA |
|||||||||
| Total Workforce Number |
|||||||||
| Gross Block (excluding CWIP, ROU, and Intangibles) Rs. Cr |
|||||||||
| Installed Capacity - Ice Cream Litres/year |
|||||||||
| Revenue Mix - Dedicated Manufacturing Percentage |
|||||||||
| Sales Volume - Shoe Division Rs. Cr |
|||||||||
Extracted by Screener AI
Documents
Announcements
- Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011 1d
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 1d
- Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 1d
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
1d - Audio recording of May 22, 2026 analyst call on Q4 and FY2026 performance uploaded.
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 1d
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
May 2026TranscriptAI SummaryPPT
-
Feb 2026Transcript PPT
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT
-
May 2025Transcript PPT REC
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT REC
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
May 2023TranscriptAI SummaryPPT
-
Feb 2023Transcript PPT
-
Nov 2022TranscriptAI SummaryPPT
-
Nov 2022Transcript PPT
-
Nov 2022TranscriptAI SummaryPPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
Feb 2022TranscriptAI SummaryPPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
May 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Aug 2020TranscriptAI SummaryPPT
-
Jul 2020TranscriptAI SummaryPPT
-
Jul 2020TranscriptAI SummaryPPT
-
Feb 2020TranscriptAI SummaryPPT
-
Nov 2019TranscriptAI SummaryPPT
-
Aug 2019TranscriptAI SummaryPPT
-
Aug 2019TranscriptAI SummaryPPT
-
Mar 2018TranscriptAI SummaryPPT
Acquired by Van group[1] Hindustan Food Limited (HFL) started a joint venture between Glaxo Smith Kline and the Dempo group to manufacture a nutritional food product under the brand name of ‘Farex’ but the venture made losses for many years as it was dependent on a single brand. In 2013, Dempo Foods Pvt. Ltd., the Holding Company of Hindustan Foods Ltd was acquired by Vanity Case India Pvt. Ltd., and the latter bought 74.45% of the paid-up share capital.